Chemical derivatization of therapeutic proteins

Richard A G Smith, Janet M. Dewdney, Robin Fears, George Poste

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Despite major advances in redesigning and producing proteins through recombinant DNA technology, many therapeutic proteins are still produced by extraction from biological tissues or fluids, or from nonrecombinant microorganisms. Modification of such proteins, to improve potency and bioavailability and reduce immunogenicity, can only be carried out post-translationally by chemical-derivatization methods. Genetic- and chemical-modification methods are not mutually exclusive, however, and may be combined to optimize protein-engineering strategies, because chemical modification can introduce structural changes that are not encoded by DNA into both recombinant, and nonrecombinant proteins.

Original languageEnglish (US)
Pages (from-to)397-403
Number of pages7
JournalTrends in Biotechnology
Volume11
Issue number9
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Recombinant Proteins
Proteins
Protein Engineering
Chemical modification
Biological Availability
Technology
Genetic engineering
DNA
Therapeutics
Microorganisms
Tissue
Fluids

ASJC Scopus subject areas

  • Bioengineering

Cite this

Chemical derivatization of therapeutic proteins. / Smith, Richard A G; Dewdney, Janet M.; Fears, Robin; Poste, George.

In: Trends in Biotechnology, Vol. 11, No. 9, 1993, p. 397-403.

Research output: Contribution to journalArticle

Smith, Richard A G ; Dewdney, Janet M. ; Fears, Robin ; Poste, George. / Chemical derivatization of therapeutic proteins. In: Trends in Biotechnology. 1993 ; Vol. 11, No. 9. pp. 397-403.
@article{661496a546534cb39b2fce9f60785005,
title = "Chemical derivatization of therapeutic proteins",
abstract = "Despite major advances in redesigning and producing proteins through recombinant DNA technology, many therapeutic proteins are still produced by extraction from biological tissues or fluids, or from nonrecombinant microorganisms. Modification of such proteins, to improve potency and bioavailability and reduce immunogenicity, can only be carried out post-translationally by chemical-derivatization methods. Genetic- and chemical-modification methods are not mutually exclusive, however, and may be combined to optimize protein-engineering strategies, because chemical modification can introduce structural changes that are not encoded by DNA into both recombinant, and nonrecombinant proteins.",
author = "Smith, {Richard A G} and Dewdney, {Janet M.} and Robin Fears and George Poste",
year = "1993",
doi = "10.1016/0167-7799(93)90100-N",
language = "English (US)",
volume = "11",
pages = "397--403",
journal = "Trends in Biotechnology",
issn = "0167-7799",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Chemical derivatization of therapeutic proteins

AU - Smith, Richard A G

AU - Dewdney, Janet M.

AU - Fears, Robin

AU - Poste, George

PY - 1993

Y1 - 1993

N2 - Despite major advances in redesigning and producing proteins through recombinant DNA technology, many therapeutic proteins are still produced by extraction from biological tissues or fluids, or from nonrecombinant microorganisms. Modification of such proteins, to improve potency and bioavailability and reduce immunogenicity, can only be carried out post-translationally by chemical-derivatization methods. Genetic- and chemical-modification methods are not mutually exclusive, however, and may be combined to optimize protein-engineering strategies, because chemical modification can introduce structural changes that are not encoded by DNA into both recombinant, and nonrecombinant proteins.

AB - Despite major advances in redesigning and producing proteins through recombinant DNA technology, many therapeutic proteins are still produced by extraction from biological tissues or fluids, or from nonrecombinant microorganisms. Modification of such proteins, to improve potency and bioavailability and reduce immunogenicity, can only be carried out post-translationally by chemical-derivatization methods. Genetic- and chemical-modification methods are not mutually exclusive, however, and may be combined to optimize protein-engineering strategies, because chemical modification can introduce structural changes that are not encoded by DNA into both recombinant, and nonrecombinant proteins.

UR - http://www.scopus.com/inward/record.url?scp=0027656447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027656447&partnerID=8YFLogxK

U2 - 10.1016/0167-7799(93)90100-N

DO - 10.1016/0167-7799(93)90100-N

M3 - Article

C2 - 7764087

AN - SCOPUS:0027656447

VL - 11

SP - 397

EP - 403

JO - Trends in Biotechnology

JF - Trends in Biotechnology

SN - 0167-7799

IS - 9

ER -